A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants
Clinical trial NCT07075640 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07075640
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-07
- Primary completion
- 2026-02-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.